Health Condition 1: N142- Nephropathy induced by unspecifieddrug, medicament or biological substance
Conditions
Interventions
Intervention1: Yoga: Validated Yoga module CKDu will be adopted :
1 hr / day
5 days a week for 3 months
Control Intervention1: wait list control group: Yoga intervention will be provided after the co
Sponsors
Dr Ramesh MN
Eligibility
Inclusion criteria
Inclusion criteria: People with diagnosed CKD (distinguishing CKD and CKDuis not possible) between 1 to 4 stages based on eGFR both men and women. Moderate and high blood pressure (traditional etiological reasons for CKD) Participants of both genders aged 18 to 60 years. Willingness to participate in a 12-week Yoga program. Patients willing to give a valid consent form.
Exclusion criteria
Exclusion criteria: People identified with genetic kidney diseases Those who had undergone renal replacement therapy Persons identified with renal carcinoma, polycystic kidney disease Those identified with severe cognitive decline, immobilized or severe mobility restrictions Those who have diagnosed neurological or psychological problems Alcoholic or addiction to any other recreational drug Recent major trauma or surgery that would interfere with participation Inability to speak or understand English or Telugu or Hindi Unable to provide informed consent Pregnant women Persons with any other serious problem that can confound the intervention effort. Uncontrolled diabetes, with single working kidney, congenital renal malformations, history of carcinoma in the past, or any other renal pathology or surgery in past. Treatment history for longstanding acute kidney pathology , Glomerular disease acute tubular necrosis, nephritic syndrome, nephritic syndrome , membranous nephropathy etcâ?¦
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| i. Creatinine and albumin ii. eGFR: Estimated Glomerular Filtration Rate iii. Renal Ultra Sound Timepoint: 2 times Baseline and end of 3rd month intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| Physiological assessments: The following psychological assessments (as secondary variables) will also be done to check for their overall health condition, mental state and QoL using standardized questionnaires: a. Kidney Disease and Quality of Life (KDQOL-SFTM) b. The Perseverative Thinking Questionnaire (PTQ) c. Hamilton Rating Scale for Anxiety (HAM-A) d. Fatigue AssessmentScale (FAS) ii. Complete Blood Count iii. Renal Function Test(Uric acid, Urea, potassium, Sodium) iv. Liver Function Test (SGOT SGPT, alkaline phosphatase, Total protein, Bilirubin) v. Thyroid Profile Investigation (T3, T4, TSH, Free T3) vi. Lipid Profile Test (HDL-high density lipoproteins, LDL-low density lipoproteins, VLDL-very low-density lipoproteins, TC-total cholesterol, TG-triglycerides) Timepoint: 2 times Baseline and end of 3rd month intervention | — |
Countries
India
Contacts
Public ContactV Sasi Kala Boppadapu
SVYASA
Outcome results
None listed